178 related articles for article (PubMed ID: 24626613)
21. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
[TBL] [Abstract][Full Text] [Related]
22. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
[TBL] [Abstract][Full Text] [Related]
23. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
24. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
[TBL] [Abstract][Full Text] [Related]
25. [Up-regulation of HOXA13 in esophageal squamous cell carcinoma of stage IIa and its effect on the prognosis].
Yan WP; Shen LY; Gu ZD; Chen KN
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):20-3. PubMed ID: 19145497
[TBL] [Abstract][Full Text] [Related]
26. Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.
Cong QX; Zhang H; Sun SX; Li HF; Wang Y; Jian S
Dis Esophagus; 2016 Aug; 29(6):621-6. PubMed ID: 25951709
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
[TBL] [Abstract][Full Text] [Related]
29. Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma.
Yang XZ; He QJ; Cheng TT; Chi J; Lei ZY; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Cell Physiol Biochem; 2018; 48(1):251-262. PubMed ID: 30007982
[TBL] [Abstract][Full Text] [Related]
30. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.
Chen J; Wen J; Zheng Y; Yang H; Luo K; Liu Q; Hu R; Tan Z; Huang Q; Fu J
Tumour Biol; 2015 Sep; 36(9):6797-803. PubMed ID: 25835977
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
34. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma.
Liu M; Hu Y; Zhang MF; Luo KJ; Xie XY; Wen J; Fu JH; Yang H
Cancer Lett; 2016 Jul; 377(1):97-104. PubMed ID: 27130665
[TBL] [Abstract][Full Text] [Related]
35. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers.
Tao J; Hua P; Wen J; Hu Y; Yang H; Xie X
Int J Clin Exp Pathol; 2015; 8(9):10975-84. PubMed ID: 26617815
[TBL] [Abstract][Full Text] [Related]
37. Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line.
Shen LY; Chen KN
Cancer Lett; 2011 Dec; 312(1):18-23. PubMed ID: 21893383
[TBL] [Abstract][Full Text] [Related]
38. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells.
Lin C; Wang Y; Wang Y; Zhang S; Yu L; Guo C; Xu H
Oncogene; 2017 Sep; 36(38):5392-5406. PubMed ID: 28534516
[TBL] [Abstract][Full Text] [Related]
40. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
